The Hanover Insurance Group has been treading water for the past six months, holding steady at $186.29. The stock also fell short of the S&P 500’s 10.9% gain during that period.

Is there a buying opportunity in The Hanover Insurance Group, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Is The Hanover Insurance Group Not Exciting?

We’re cautious about The Hanover Insurance Group. Here are three reasons why THG doesn’t excite us, plus one stock we’d rather own.

1. Long-Term Revenue Growth Disappoints

Big picture, insurers generate revenue from three key sources. The first is the core business of underwriting policies. The second source is income from investing the “float” (premiums collected upfront not yet paid out as claims) in assets such as fixed-income assets and equities. The third is fees from various sources such as policy administration, annuities, or other value-added services.

Regrettably, The Hanover Insurance Group’s revenue grew at a mediocre 6.7% compounded annual growth rate over the last five years. This fell short of our benchmark for the insurance sector.

2. Net Premiums Earned Point to Soft Demand

Insurers sell policies then use reinsurance (insurance for insurance companies) to protect themselves from large losses. Net premiums earned are therefore what's collected from selling policies less what’s paid to reinsurers as a risk mitigation tool.

The Hanover Insurance Group’s net premiums earned has grown at a 4.2% annualized rate over the last two years, worse than the broader insurance industry and in line with its total revenue.

3. Growing BVPS Reflects Strong Asset Base

Book value per share (BVPS) serves as a key indicator of an insurer’s financial stability, reflecting a company’s ability to maintain adequate capital levels and meet its long-term obligations to policyholders.

Although The Hanover Insurance Group’s BVPS increased by a meager 3.7% annually over the last five years, the good news is that its growth has recently accelerated as BVPS grew at an impressive 19.8% annual clip over the past two years (from $70.27 to $100.86 per share).

Final Judgment

The Hanover Insurance Group isn’t a terrible business, but it doesn’t pass our quality test. With its shares underperforming the market lately, the stock trades at 1.7× forward P/B (or $186.29 per share). Investors with a higher risk tolerance might like the company, but we don’t really see a big opportunity at the moment. We’re fairly confident there are better investments elsewhere. We’d suggest looking at one of our all-time favorite software stocks.

Stocks We Would Buy Instead of The Hanover Insurance Group

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.